New Key Statistics Module, Z-Score and F-Score
NYSE:CVS Key Ratios
| Market Cap $ M | 89,509.76 |
| Enterprise Value $ M | 154,925.74 |
| P/E(ttm) | 30.57 |
| PE Ratio without NRI | 30.57 |
| Forward PE Ratio | 8.04 |
| Price/Book | 1.23 |
| Price/Sales | 0.27 |
| Price/Free Cash Flow | 5.12 |
| Price/Owner Earnings | 5.73 |
| Payout Ratio % | 1.05 |
| Revenue (TTM) $ M | 339,204.00 |
| EPS (TTM) $ | 2.28 |
| Beneish M-Score | -2.45 |
| 10-y EBITDA Growth Rate % | 4.20 |
| 5-y EBITDA Growth Rate % | 3.00 |
| y-y EBITDA Growth Rate % | -37.60 |
| EV-to-EBIT | 23.86 |
| EV-to-EBITDA | 14.46 |
| PEG | 10.19 |
| Shares Outstanding M | 1,284.40 |
| Net Margin (%) | 0.86 |
| Operating Margin % | 4.43 |
| Pre-tax Margin (%) | 1.21 |
| Quick Ratio | 0.64 |
| Current Ratio | 0.86 |
| ROA % (ttm) | 1.24 |
| ROE % (ttm) | 4.05 |
| ROIC % (ttm) | 6.05 |
| Dividend Yield % | 3.37 |
| Altman Z-Score | 2.02 |
| Piotroski F-Score | 5.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | N |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | N |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | Y |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | Y |
CVS Number of Guru Trades
CVS Volume of Guru Trades
Gurus Latest Trades with NYSE:CVS
No Available Data
NYSE:CVS is held by these investors
Total 14
CVS Health Corp Insider Transactions
No Available Data
News about NYSE:CVS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers